Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Professional Licensing Ce topic
No spam. Unsubscribe anytime.
Commission grants temporary CE extensions and reminds first‑time managers of responsibilities
Summary
The commission granted temporary continuing‑education extensions to several pharmacists and used a portion of the meeting to brief first‑time pharmacy managers on licensing obligations, reporting duties, tech ratios and diversion reporting timelines.
Connecticut’s Commission of Pharmacy granted time‑limited extensions for continuing education (CE) to several licensees and conducted an extended orientation for first‑time pharmacy managers.
CE extensions and rulings: the commission approved an extension request for Vincent Bucarey (motion approved) after staff review of his NABP CPE Monitor transcript showed he had completed 20.25 hours but still needed five live hours for 2024 compliance; the transcript shows the board accepted his extension. The commission granted Vanessa Pierre Louis an extension until May 1 to complete missing credits and noted she must still complete the full 15 hours required for the current year. Commissioner and staff guidance made clear that licensees must subscribe to the CPE Monitor and that renewals are calendar‑year based (January 1–December 31). The commission also granted Vikram (Vikram) Patel an extension through May to make up live CE credits from a prior renewal cycle and to make up required live credits for the current cycle; the transcript records a motion granting an extension with the expectation the licensee will complete required live credits by May.
First‑time manager briefing: the chairman led a prepared orientation for first‑time pharmacy managers covering manager duties and common compliance pitfalls. Key points included: pharmacy managers must work at least 35 hours per week (exceptions were noted during COVID), maintain timely license and CE records, understand technician‑to‑pharmacist ratios (3:1 certified, 4:1 for certain vaccine administration; ratios may change pending new regs), and report losses of controlled substances within 72 hours. The chair emphasized that manager responsibilities are personal and not delegable to corporate supervisors; managers should notify the department immediately upon leaving a manager role.
Why it matters: CE compliance and manager accountability are core regulatory tools to ensure safe pharmacy practice. The board signaled increased audit activity on CE reporting and urged managers to maintain accurate records and to report events promptly to Drug Control.
Ending: administrators and auditors said they will follow up on extension conditions and that audits of CEs will be increased.
